Retraction
Phillygenin Protects the Intestinal Barrier from Dysfunction via let-7b Signaling Pathway and Regulation of Intestinal Microbiota
Paper Information
Record ID:
56337
Author(s):
Journal:
Publication Date:
March 16, 2022
Retraction Date:
October 04, 2023
(2.1 years years ago)
Subjects:
Institutions:
- Department of Clinical Nutrition, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510799, China
- Department of AnoRectal Surgery, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510799, China
- Department of Emergency, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510799, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Informed/Patient Consent - None/Withdrawn
- Investigation by Journal/Publisher
- Investigation by Third Party
- Lack of IRB/IACUC Approval and/or Compliance
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9863260Citations (8)
8
Total Citations2
Post-Retraction(25.0%)
5
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
2
Within 1 year
0
After 2+ years
333
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Potential medicinal application of phillygenin and atractylon in medicine as drug candidates with their molecular mechanism
Kanika Patel, Dinesh K. Patel
Food Bioscience
Published: Sep 2024
1 citation
1 citation
333 days after retraction
<i>Forsythia suspensa</i> (Thunb.) Vahl extract ameliorates ulcerative colitis via inhibiting NLRP3 inflammasome activation through the TLR4/MyD88/NF‐κB pathway
Xiao Tong, Li Chen, Shijun He et al. (10 authors)
Immunity Inflammation and Disease
Open Access
Published: Nov 2023
12 citations
12 citations
28 days after retraction
A comprehensive review on pharmacological, toxicity, and pharmacokinetic properties of phillygenin: Current landscape and future perspectives
Cheng Wang, Rui Wu, Shenglin Zhang et al. (8 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Sep 2023
21 citations
21 citations
30 days before retraction
Clinical efficacy, pharmacodynamic components, and molecular mechanisms of antiviral granules in the treatment of influenza: A systematic review
Juan Su, Xinming Chen, Yi-ling Xie et al. (11 authors)
Journal of Ethnopharmacology
Published: Aug 2023
11 citations
11 citations
56 days before retraction
Phillygenin Attenuated Colon Inflammation and Improved Intestinal Mucosal Barrier in DSS-induced Colitis Mice via TLR4/Src Mediated MAPK and NF-κB Signaling Pathways
Huanhuan Xue, Jinɡjinɡ Li, Shi-Fei Li et al. (9 authors)
International Journal of Molecular Sciences
Open Access
Published: Jan 2023
41 citations
41 citations
254 days before retraction
Retracted: Phillygenin Protects the Intestinal Barrier from Dysfunction via let‐7b Signaling Pathway and Regulation of Intestinal Microbiota
Journal of Healthcare Engineering
Journal of Healthcare Engineering
Open Access
Published: Jan 2023
276 days before retraction
Hepatoprotective effect of phillygenin on carbon tetrachloride-induced liver fibrosis and its effects on short chain fatty acid and bile acid metabolism
Cheng Wang, Cheng Ma, Ke Fu et al. (7 authors)
Journal of Ethnopharmacology
Published: Jun 2022
26 citations
26 citations
475 days before retraction
Quick Stats
Total Citations:
14
Years Since Retraction:
2.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025